Cloud EHR And AI Automation Will Unlock New Opportunities

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

12 Apr 25

Updated

01 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-20.7%

7D

0.3%

Loading

1Y

-20.7%

7D

0.3%

You can edit this narrative until Dec 2 4:15 AM. Then, changes will post as Updates.

Author's Valuation

US$6.3150.7% undervalued

AnalystConsensusTarget Fair Value

Shared on 01 Dec 25

Fair value Increased 9.78%

CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum

CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.

Shared on 17 Nov 25

Fair value Increased 21%

CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability

CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.

Shared on 01 May 25

Fair value Increased 7.22%

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 0.30%

AnalystConsensusTarget has increased revenue growth from 3.0% to 3.6%, decreased profit margin from 19.3% to 6.5%, increased future PE multiple from 11.8x to 35.3x and decreased shares outstanding growth rate from 0.3% to 0.1%.

AnalystConsensusTarget Fair Value

US$6.31

50.7% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

10.85%

Healthtech revenue growth rate

10.78%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.38%

Calculation

US$14.84m

Earnings '28

x

22.73x

PE Ratio '28

=

US$337.35m

Market Cap '28

US$337.35m

Market Cap '28

/

42.64m

No. shares '28

=

US$7.91

Share Price '28

US$7.91 Share Price '28

Discounted to 2025 @ 8.36% p.a.

=

US$6.22

Fair Value '25